Clinical Trial Update: Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing pirfenidone effects on glomerular filtration rate and albuminuria in patients with diabetic nephropathy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Diabetic Nephropathy

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Diabetic Nephropathy, Albuminuria | Phase 3 | Status: COMPLETED